CS Genetics
Discovery Tools (Healthcare)
CS Genetics valuation and funding history | Last updated: September 20, 2022 | 1 funding rounds
Current Valuation
N/A
As of September 20, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Later Stage VC (Series A)
$16.9M
Last Funding
Sep 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| September 20, 2022 | Later Stage VC (Series A) | $16.9M | N/A | - |
Valuation Analysis
Current Valuation Metrics
CS Genetics is currently valued at N/A as of September 20, 2022.
What is CS Genetics Worth in 2026?
CS Genetics is a leading private company in the Discovery Tools (Healthcare) sector. Track CS Genetics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How CS Genetics Valuation is Determined
Private company valuations like CS Genetics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.